In Vivo Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral Vectors

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Human Gene Therapy

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/104303403322168028PMID 12908970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene.

  2003cited by this paper
• Generation of HIV-1 derived lentiviral vectors.

  2002cited by this paper
• A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos

  2002cited by this paper
• Transduction of a gene expression cassette using advanced generation lentiviral vectors.

  2002cited by this paper
• Efficient Gene Delivery and Targeted Expression to Hepatocytes In Vivo by Improved Lentiviral Vectors

  2002influential reference
• Transcriptional Targeting of Lentiviral Vectors by Long Terminal Repeat Enhancer Replacement

  2002cited by this paper
• Expression from cell type-specific enhancer-modified retroviral vectors after transduction: influence of marker gene stability.

  2002cited by this paper
• A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.

  2002cited by this paper
• Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.

  2002cited by this paper
• Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors

  2002cited by this paper
• Tumor Regression by Targeted Gene Delivery to the Neovasculature

  2002cited by this paper
• Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma

  2002cited by this paper
• Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.

  2002cited by this paper
• Tissue-specific gene therapy directed to tumor angiogenesis

  2001cited by this paper
• Retargeting gene delivery using surface-engineered retroviral vector particles.

  2001cited by this paper
• Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

  2001cited by this paper
• Analysis of Cell-Specific Promoters for Viral Gene Therapy Targeted at the Vascular Endothelium

  2001cited by this paper
• Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

  2001cited by this paper
• A gene trap vector system for identifying transcriptionally responsive genes

  2001influential reference
• Adhesion events in angiogenesis.

  2001cited by this paper
• Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.

  2001cited by this paper
• Tie receptors: new modulators of angiogenic and lymphangiogenic responses

  2001cited by this paper
• Genes expressed in human tumor endothelium.

  2000cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Cancer: looking outside the genome

  2000cited by this paper
• Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

  2000cited by this paper
• Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy

  2000cited by this paper
• Gene therapy: trials and tribulations

  2000cited by this paper
• Calcineurin Controls the Transcription of Na+/Ca2+ Exchanger Isoforms in Developing Cerebellar Neurons*

  2000cited by this paper
• Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

  2000cited by this paper
• The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice.

  1999cited by this paper
• Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

  1999cited by this paper
• Role of Ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter

  1999cited by this paper
• Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis.

  1998cited by this paper
• Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

  1998cited by this paper
• The Human ICAM-2 Promoter is Endothelial Cell-specific in Vitro and in Vivo and Contains Critical Sp1 and GATA Binding Sites*

  1998cited by this paper
• Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice.

  1997cited by this paper
• Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ

  1997cited by this paper
• The Bystander Effect of the Nitroreductase/CB 1954 Enzyme/Prodrug System Is Due to a Cell-Permeable Metabolite

  1997cited by this paper
• The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos

  1991cited by this paper
• HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Identification of Vascular Endothelial Growth Factor (VEGF) Receptor-2 ( Flk-1 ) Promoter/Enhancer Sequences Sufficient for Angioblast and Endothelial Cell-Specific Transcription in Transgenic Mice

  year unknowninfluential reference

• Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?

  2022cites this paper
• Short regulatory DNA sequences to target brain endothelial cells for gene therapy

  2021cites this paper
• Vascular Endothelial Cells: Heterogeneity and Targeting Approaches

  2021cites this paper
• NEW METHODS FOR AORTIC DISEASE MODELING USING LENTIVIRAL VECTORS

  2020cites this paper
• Nanocarrier-based systems for targeted and site specific therapeutic delivery.

  2019cites this paper
• Inhibition of constructed SEC3-ES lentiviral vector to proliferation, migration of Hela cells.

  2019cites this paper
• New Methods for Disease Modeling Using Lentiviral Vectors.

  2018cites this paper
• A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.

  2017cites this paper
• Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7

  2017cites this paper
• Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress

  2017cites this paper
• Different but synergistic effects of bone marrow-derived VEGFR2+ and VEGFR2−CD45+ cells during hepatocellular carcinoma progression

  2016cites this paper
• Genetic manipulation of brain endothelial cells in vivo.

  2016cites this paper
• An endothelial TLR4‐VEGFR2 pathway mediates lung protection against oxidant‐induced injury

  2016cites this paper
• A transgenic quail model that enables dynamic imaging of amniote embryogenesis

  2015cites this paper
• Characterization of PI (breast cancer cell special peptide) in MDA-MB-231 breast cancer cells and its potential therapeutic applications.

  2015cites this paper
• Vaccines & Vaccine Technologies

  2014cites this paper
• The role IL-1 in tumor-mediated angiogenesis

  2014cites this paper
• Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression

  2014cites this paper
• Generation and analysis of lentivirus expressing a 2A peptide-linked bicistronic fluorescent construct.

  2014cites this paper
• Giulia Escobar Inhibits Breast Cancer Progression Delivery α Genetic Engineering of Hematopoiesis for Targeted IFN -

  2013cites this paper
• Targeted Lentiviral Vectors: Current Applications and Future Potential

  2013cites this paper
• Characterization of a 3rd Generation Lentiviral Vector Pseudotyped With Nipah Virus Envelope Proteins For Endothelial Cell Transduction

  2013cites this paper
• Rapid In Vitro Derivation of Endothelium Directly From Human Cancer Cells

  2013cites this paper
• Transgenesis and imaging in birds, and available transgenic reporter lines

  2013cites this paper
• Preferential Lentiviral Targeting of Astrocytes in the Central Nervous System

  2013cites this paper
• Lentiviral vectors: a versatile tool to fight cancer.

  2013cites this paper
• Cell and Tissue Gene Targeting with Lentiviral Vectors

  2012cites this paper
• Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.

  2012cites this paper
• Transient embolization with microspheres of polyhydroxyalkanoate renders efficient adenoviral transduction of pancreatic capillary in vivo

  2012cites this paper
• STIM1 Restores Coronary Endothelial Function in Type 1 Diabetic Mice

  2012cites this paper
• Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients

  2012cites this paper
• FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells

  2012cites this paper
• Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts.

  2012cites this paper
• Lentiviral Vectors and Gene Therapy

  2012cites this paper
• Viruses in pharmaceutical research: pulmonary vascular disease.

  2011cites this paper
• Advances in imaging gene-directed enzyme prodrug therapy.

  2011cites this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cites this paper
• Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

  2011cites this paper
• Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins

  2011cites this paper
• Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications.

  2011cites this paper
• Angiopoietins, abdominal aortic aneurysm and atherosclerosis.

  2011cites this paper
• Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models

  2011cites this paper
• Dynamic Analysis of Vascular Morphogenesis Using Transgenic Quail Embryos

  2010cites this paper
• Construction of a novel expression cassette for increasing transgene expression in vivo in endothelial cells of large blood vessels

  2010cites this paper
• Development of Vascular Disrupting Agents

  2010cites this paper
• A novel gene delivery system targeting Tie2 for cancer gene therapy.

  2010cites this paper
• Vascular‐Targeted Molecular Therapy

  2010cites this paper
• Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential

  2010cites this paper
• Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation

  2010cites this paper
• Genetically engineered mouse models in cancer research.

  2010cites this paper
• Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition

  2009cites this paper
• Shear stress-induced transcriptional regulation via hybrid promoters as a potential tool for promoting angiogenesis

  2009cites this paper
• Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK

  2009cites this paper
• Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent

  2009cites this paper
• Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy?

  2009cites this paper
• Genetic manipulation of endothelial cells by viral vectors

  2009cites this paper
• Transcriptional targeting of tumor endothelial cells for gene therapy.

  2009cites this paper
• Non-hematopoietic Stem and Progenitor Cells Derived From Human Umbilical Cord Blood

  2009cites this paper
• [Lentiviral vectors].

  2008cites this paper
• Chapter 11. The role of bone marrow-derived cells in tumor angiogenesis and metastatic progression.

  2008cites this paper
• Expression-targeted gene therapy for the treatment of transitional cell carcinoma

  2008cites this paper
• Specific monitoring of cardiomyogenic and endothelial differentiation by dual promoter-driven reporter systems in bone marrow mesenchymal stem cells

  2008influential citation
• Lentiviral vectors

  2008cites this paper
• Efficient targeted transduction of primary human endothelial cells with dual‐targeted lentiviral vectors

  2008cites this paper
• Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy.

  2008cites this paper
• Gene-therapy delivery strategies in cardiology.

  2008cites this paper
• Human CMV immediate‐early enhancer: a useful tool to enhance cell‐type‐specific expression from lentiviral vectors

  2008cites this paper
• Overview of Angiogenesis During Tumor Growth

  2008cites this paper
• Homing and Differentiation of Endothelial Progenitor Cells

  2008cites this paper
• Viral, Nonviral, and Physical Methods for Gene Delivery

  2008cites this paper
• Stable EGFP gene expression in C6 glioma cell line after transduction with HIV-1-based lentiviral vector

  2008cites this paper
• Concepts in genetic medicine

  2008cites this paper
• Generating transgenic quail using lentiviruses.

  2008cites this paper
• Lentiviral and Retroviral Vector Systems

  2007cites this paper
• Lentiviral vectors for regulated and liver directed gene therapy

  2007cites this paper
• Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression.

  2007cites this paper
• Gene therapy targeting to tumor endothelium

  2007cites this paper
• Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

  2007cites this paper
• Oncolytic viruses in cancer therapy

  2007cites this paper
• Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics

  2007cites this paper
• Chapter 37 – Therapeutic Potential of Systemic Gene Transfer Strategy for Hypertension and Cardiovascular Disease

  2007cites this paper
• The development of viral vectors for targeted gene delivery to atherosclerotic plaques

  2007cites this paper
• Targeted gene-delivery strategies for angiostatic cancer treatment.

  2007cites this paper
• Anti-angiogenic gene therapy of cancer: current status and future prospects.

  2007cites this paper
• Viral vectors for gene-directed enzyme prodrug therapy.

  2006cites this paper
• Evidence for disease‐regulated transgene expression in the brain with use of lentiviral vectors

  2006cites this paper
• Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors.

  2006influential citation
• Promoter Dependence of Transgene Expression by Lentivirus‐Transduced Human Blood–Derived Endothelial Progenitor Cells

  2006cites this paper
• Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis.

  2006cites this paper
• Lentiviral vectors as tools for gene manipulation

  2006cites this paper
• ACE2: A novel therapeutic target for cardiovascular diseases.

  2006cites this paper
• Tumor vascular targeting therapy with viral vectors.

  2006cites this paper
• Efficient infection of tumor endothelial cells by a capsid-modified adenovirus

  2006cites this paper
• Antibodies and peptides in cancer therapy.

  2006cites this paper
• Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells.

  2006cites this paper
• Development and characterization of a synthetic promoter for selective expression in proliferating endothelial cells

  2006cites this paper
• Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.

  2005cites this paper
• Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

  2005influential citation
• Contribution of bone marrow–derived endothelial cells to human tumor vasculature

  2005cites this paper
• Gene therapy for cholangiocarcinoma

  2005cites this paper